{
     "PMID": "27863851",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170810",
     "LR": "20180228",
     "IS": "1872-6216 (Electronic) 0047-6374 (Linking)",
     "VI": "162",
     "DP": "2017 Mar",
     "TI": "Long-term exposition to a high fat diet favors the appearance of beta-amyloid depositions in the brain of C57BL/6J mice. A potential model of sporadic Alzheimer's disease.",
     "PG": "38-45",
     "LID": "S0047-6374(16)30085-9 [pii] 10.1016/j.mad.2016.11.002 [doi]",
     "AB": "AIMS: The sporadic and late-onset form of Alzheimer's disease (AD) constitutes the most common form of dementia. This non-familiar form could be a consequence of metabolic syndrome, characterized by obesity and the development of a brain-specific insulin resistance known as type III diabetes. This work demonstrates the development of a significant AD-like neuropathology due to these metabolic alterations. METHODS: C57BL/6J mice strain were divided into two groups, one fed with a diet rich in palmitic acid (high-fat diet, HFD) since their weaning until 16 months of age, and another group used as a control with a regular diet. The analyses were carried out in the dentate gyrus area of the hippocampus using a Thioflavin-S stain and immunofluorescence assays. RESULTS: The most significant finding of the present research was that HFD induced the deposition of the betaA peptide. Moreover, the diet also caused alterations in different cell processes, such as increased inflammatory reactions that lead to a decrease in the neuronal precursor cells. In addition, the results show that there were also dysregulations in normal autophagy and apoptosis, mechanisms related to betaA formation. CONCLUSIONS: The present findings confirm that HFD favors the formation of betaA depositions in the brain, a key feature of AD, supporting the metabolic hypothesis of sporadic AD.",
     "CI": [
          "Copyright (c) 2016 Elsevier Ireland Ltd. All rights reserved."
     ],
     "FAU": [
          "Busquets, Oriol",
          "Ettcheto, Miren",
          "Pallas, Merce",
          "Beas-Zarate, Carlos",
          "Verdaguer, Ester",
          "Auladell, Carme",
          "Folch, Jaume",
          "Camins, Antoni"
     ],
     "AU": [
          "Busquets O",
          "Ettcheto M",
          "Pallas M",
          "Beas-Zarate C",
          "Verdaguer E",
          "Auladell C",
          "Folch J",
          "Camins A"
     ],
     "AD": "Departament de Bioquimica i Biotecnologia, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus, Tarragona, Spain; Departament de Farmacologia, Toxicologia i Quimica Terapeurica, Facultat de Farmacia i Ciencies de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Departament de Farmacologia, Toxicologia i Quimica Terapeurica, Facultat de Farmacia i Ciencies de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Departament de Farmacologia, Toxicologia i Quimica Terapeurica, Facultat de Farmacia i Ciencies de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Insitutut de Neurociencies, Universitat de Barcelona, Barcelona, Spain. Laboratorio de Regeneracion y Desarrollo Neural, Instituto de Neurobiologia, Departamento de Biologia Celular y Molecular, CUCBA, Guadalajara, Mexico. Departament de Biologia Cel.lular, Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Insitutut de Neurociencies, Universitat de Barcelona, Barcelona, Spain. Departament de Biologia Cel.lular, Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Insitutut de Neurociencies, Universitat de Barcelona, Barcelona, Spain. Departament de Bioquimica i Biotecnologia, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus, Tarragona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Departament de Farmacologia, Toxicologia i Quimica Terapeurica, Facultat de Farmacia i Ciencies de l'Alimentacio, Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Insitutut de Neurociencies, Universitat de Barcelona, Barcelona, Spain. Electronic address: camins@ub.edu.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20161115",
     "PL": "Ireland",
     "TA": "Mech Ageing Dev",
     "JT": "Mechanisms of ageing and development",
     "JID": "0347227",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Dietary Fats)"
     ],
     "SB": "IM",
     "MH": [
          "Aging/drug effects/*metabolism",
          "Alzheimer Disease/chemically induced/*metabolism/pathology",
          "Amyloid beta-Peptides/*metabolism",
          "Animals",
          "Brain/*metabolism/pathology",
          "Dietary Fats/*adverse effects/pharmacology",
          "Disease Models, Animal",
          "Humans",
          "Mice"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*AD",
          "*AMP-activated protein kinase",
          "*AMPK",
          "*ANS",
          "*Alzheimer's disease",
          "*Abeta",
          "*BACE1",
          "*BBB",
          "*CSF",
          "*DIO",
          "*HCD",
          "*HFD",
          "*IGF-1",
          "*LOAD",
          "*MAPK",
          "*PTP1beta",
          "*T2DM",
          "*autonomic nervous system",
          "*beta-site APP-cleaving enzyme 1",
          "*brain blood barrier",
          "*cerebrospinal fluid",
          "*diet-induced obesity",
          "*high calorie diet",
          "*high-fat diet",
          "*insulin-like growth factor-1",
          "*late-onset Alzheimer's disease",
          "*mitogen-activated protein kinase",
          "*protein tyrosine phosphatase 1beta",
          "*type 2 diabetes mellitus",
          "*beta-amyloid"
     ],
     "EDAT": "2016/11/20 06:00",
     "MHDA": "2017/08/11 06:00",
     "CRDT": [
          "2016/11/20 06:00"
     ],
     "PHST": [
          "2016/06/02 00:00 [received]",
          "2016/09/26 00:00 [revised]",
          "2016/11/11 00:00 [accepted]",
          "2016/11/20 06:00 [pubmed]",
          "2017/08/11 06:00 [medline]",
          "2016/11/20 06:00 [entrez]"
     ],
     "AID": [
          "S0047-6374(16)30085-9 [pii]",
          "10.1016/j.mad.2016.11.002 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Mech Ageing Dev. 2017 Mar;162:38-45. doi: 10.1016/j.mad.2016.11.002. Epub 2016 Nov 15.",
     "term": "hippocampus"
}